MoviePass Rival Sinemia Is in It for the Long Haul

The biggest question around MoviePass and its $10-per-month unlimited subscription has never been whether it’s a good deal. It’s whether—or how long—it can possibly last. But there’s another monthly moviegoing plan that has largely dodged those existential doubts. In fact, in some parts of the world, it even turns a profit. Imagine that. That company …

Continue reading “MoviePass Rival Sinemia Is in It for the Long Haul”